Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P920048/S030

Rapid fFN for the TLiIQ System

Hologic, Inc. · Decision date Aug 26, 2026

FDA DECISIONP920048/S030

What did the FDA decide?

FDA records P920048/S030 as a supplement to PMA P920048, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 26, 2026.

FDA approval order statement

to modify the paper release liner used on the backing card for the manufacture of the Rapid fFN Cassette Kit of the TLiIQ System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Toxicology
Decision date
Aug 26, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P920048/S030
Regulatory pathway
PMA supplement
Applicant
Hologic, Inc.
Product code
LKV
Decision code
OK30
Decision date
Aug 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: ENZYME IMMUNOASSAY, FETAL FIBRONECTIN.

Applicant
Hologic, Inc.
Product code
LKV
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P920048/S028 · Related supplement

    Rapid fFN for the TLiIQ System

  2. P920048/S029 · Related supplement

    Rapid fFN for the TLiIQ System

  3. P920048/S030 received

    Application receipt date recorded by FDA.

  4. P920048/S030 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P920048. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P920048

Product / regulatory recordCompanyPathwayDecision dateSource
Hologic, Inc.PMA supplementMar 5, 2026FDA
Hologic, Inc.PMA supplementMar 5, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hologic, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1240 Elko Dr., Sunnyvale, CA, 94089

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records